Oracle (NYSE:ORCL) Stock Rating Upgraded by Melius

Oracle (NYSE:ORCLGet Free Report) was upgraded by equities researchers at Melius from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Monday, Marketbeat reports. The firm presently has a $210.00 price target on the enterprise software provider’s stock. Melius’ price target suggests a potential upside of 25.40% from the stock’s previous close.

Other equities analysts have also issued reports about the company. Barclays upped their target price on Oracle from $160.00 to $172.00 and gave the stock an “overweight” rating in a research note on Tuesday, September 10th. Stifel Nicolaus upped their target price on Oracle from $135.00 to $155.00 and gave the stock a “hold” rating in a research note on Tuesday, September 10th. DA Davidson upped their target price on Oracle from $105.00 to $140.00 and gave the stock a “neutral” rating in a research note on Tuesday, September 10th. Mizuho upped their target price on Oracle from $170.00 to $185.00 and gave the stock an “outperform” rating in a research note on Tuesday, September 10th. Finally, Sanford C. Bernstein increased their price objective on Oracle from $159.00 to $171.00 and gave the company an “outperform” rating in a research report on Wednesday, June 12th. Eleven research analysts have rated the stock with a hold rating and twenty have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $163.88.

View Our Latest Report on Oracle

Oracle Stock Performance

NYSE:ORCL opened at $167.47 on Monday. The company has a debt-to-equity ratio of 6.68, a quick ratio of 0.72 and a current ratio of 0.72. Oracle has a 52-week low of $99.26 and a 52-week high of $173.99. The firm has a market cap of $464.05 billion, a price-to-earnings ratio of 45.14, a PEG ratio of 2.95 and a beta of 1.01. The business’s fifty day moving average is $140.89 and its 200 day moving average is $130.95.

Oracle (NYSE:ORCLGet Free Report) last released its quarterly earnings data on Monday, September 9th. The enterprise software provider reported $1.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.33 by $0.06. The company had revenue of $13.31 billion for the quarter, compared to analyst estimates of $13.23 billion. Oracle had a return on equity of 171.38% and a net margin of 20.40%. The firm’s revenue for the quarter was up 6.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.95 EPS. Research analysts predict that Oracle will post 5.06 EPS for the current year.

Insiders Place Their Bets

In other Oracle news, Chairman Lawrence Joseph Ellison sold 1,125,000 shares of the stock in a transaction that occurred on Monday, July 15th. The stock was sold at an average price of $143.69, for a total value of $161,651,250.00. Following the completion of the sale, the chairman now owns 1,145,732,353 shares in the company, valued at approximately $164,630,281,802.57. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other news, Chairman Lawrence Joseph Ellison sold 1,125,000 shares of the stock in a transaction that occurred on Monday, July 15th. The stock was sold at an average price of $143.69, for a total value of $161,651,250.00. Following the completion of the transaction, the chairman now owns 1,145,732,353 shares of the company’s stock, valued at approximately $164,630,281,802.57. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Jeffrey Berg sold 22,500 shares of the stock in a transaction that occurred on Thursday, June 20th. The stock was sold at an average price of $143.12, for a total value of $3,220,200.00. Following the completion of the transaction, the director now directly owns 210,712 shares of the company’s stock, valued at approximately $30,157,101.44. The disclosure for this sale can be found here. In the last 90 days, insiders sold 1,868,820 shares of company stock worth $267,819,424. 42.80% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in ORCL. Contour Asset Management LLC increased its position in Oracle by 41.5% during the 4th quarter. Contour Asset Management LLC now owns 2,192,950 shares of the enterprise software provider’s stock valued at $231,203,000 after buying an additional 643,490 shares in the last quarter. Hancock Whitney Corp increased its position in Oracle by 12.7% during the 4th quarter. Hancock Whitney Corp now owns 29,301 shares of the enterprise software provider’s stock valued at $3,089,000 after buying an additional 3,291 shares in the last quarter. Heritage Wealth Advisors increased its position in Oracle by 0.6% during the 4th quarter. Heritage Wealth Advisors now owns 16,995 shares of the enterprise software provider’s stock valued at $1,792,000 after buying an additional 109 shares in the last quarter. Seven Mile Advisory increased its position in Oracle by 10.6% during the 4th quarter. Seven Mile Advisory now owns 5,236 shares of the enterprise software provider’s stock valued at $552,000 after buying an additional 502 shares in the last quarter. Finally, Goelzer Investment Management Inc. increased its position in Oracle by 25.0% during the 1st quarter. Goelzer Investment Management Inc. now owns 7,492 shares of the enterprise software provider’s stock valued at $941,000 after buying an additional 1,500 shares in the last quarter. Institutional investors own 42.44% of the company’s stock.

Oracle Company Profile

(Get Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Featured Stories

Analyst Recommendations for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.